Title: Comprehensive coverage of glycolysis and pentose phosphate metabolic pathways by isomer-selective accurate targeted hydrophilic interaction liquid chromatography-tandem mass spectrometry assay
Journal: Analytical Chemistry
Published: 2024
Background
The accurate liquid chromatography-tandem mass spectrometry analysis of phosphorylated isomers from glycolysis and pentose phosphate pathways is a challenging analytical problem in metabolomics due to extraction problems from the biological matrix, adherence to stainless steel surfaces leading to tailing in LC, and incomplete separation of hexose and pentose phosphate isomers. There has been a lot of research on the analysis of sugar phosphates, and many incremental improvements have been made over time. However, each of these approaches has some limitations. The goal of this study was to present an improved robust HILIC-ESI-MS/MS method for accurate quantification of all metabolites of the glycolysis and pentose phosphate pathways, overcoming peak shape and retention time repeatability problems (ascribed to HILIC) and securing assay specificity for the isomers while also considering potential interferences from other pathways, such as mannose and lactose metabolism.
Methods
HILIC-ESI-MS/MS
Results
As shown in Figure 1, the four pentose phosphates are also separated. Ru5P and Xu5P were only partially separated, while Ru1P and Ri5P are fully baseline-separated. This separation should be suitable to allow at least an estimation of Ru5P and Xu5P, while the other two pentose phosphates can be determined without assay specificity compromises. Moreover, all the other target metabolites also show satisfactory peak shapes, and other critical isomeric peak pairs were fully resolved (2PG and 3PG, GA3P and DHAP). Pyr and Lac, which must be separated to avoid M + 2 isotopologue overlap, were fully baseline-resolved. The method also covers several bis-phosphates (F16P2 and 2,3PG), as well as PRPP with phosphate at the 5-position and a pyrophosphate group in position 1 of ribose. They exhibit symmetric peaks as well, and all target metabolites can be separated within 20 min.
Figure 1. Extracted ion chromatogram and isomer separation of HMP analytes found in the HeLa cell sample extract (3 × 106 cells) with optimized method conditions.
Erastin was used to induce ferroptosis in HEK293 cells, an immortalized human embryonic kidney cell line. Erastin inhibits the cystine–glutamate antiporter system Xc, leading to cysteine deprivation and cellular deficiency to synthesize the antioxidant glutathione. It is accompanied by reactive oxygen species (ROS) accumulation due to mitochondrial dysfunction and causes an avalanche of metabolic alterations. Figure 2A shows the heat map of the glycolysis and PPP metabolites of a two-group comparison (erastin-induced ferroptosis vs control, i.e., untreated HEK293 cells). Cluster analysis provides a classification according to the two groups based on the glycolytic and PPP metabolite concentration levels. A volcano plot in Figure 2B generated by comparing metabolite levels of these two groups by univariate statistics reveals that the glycolytic metabolites F16P2, 2PG, 2,3BPG, and 3PG were significantly upregulated (p-value of <0.05) with a fold-change of >2 in the erastin-induced ferroptosis group. Enhanced glycolysis in cells with ferroptosis was further confirmed by the enhanced glucose uptake.
Figure 2. (A) Heatmaps displaying an overview of metabolite abundance distribution, with comparison between erastin-induced ferroptotic cell samples (ER) versus the control (CTRL). (B) Volcano plots showing the comparison between ferroptosis-induced (erastin) samples and the control (p-value threshold 0.05). (C) Representative boxplots of significantly increased metabolites (2PG, 3PG, 2,3BPG, and F16P2) found in HEK293 cell extract samples in which ferroptosis was induced compared to untreated ones (control).[1]
Reference
- Serafimov K.; et al. Comprehensive coverage of glycolysis and pentose phosphate metabolic pathways by isomer-selective accurate targeted hydrophilic interaction liquid chromatography-tandem mass spectrometry assay. Anal Chem. 96(43):17271-17279. https://pubs.acs.org/doi/full/10.1021/acs.analchem.4c03490